Masahiro Mori

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Clinical features and prognosis of Miller Fisher syndrome

Masahiro Mori, Satoshi Kuwabara, Toshio Fukutake et al. · Neurology · 2001 · 418 citations

Medicine, Neurology, Neuro-ophthalmology +9

Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial

Masayuki Tahara, Tomoko Oeda, Kazumasa Okada et al. · The Lancet Neurology · 2020 · 368 citations

Medicine, Clinical Sciences, Neurology +5

Identification of major proteins in the lipid droplet-enriched fraction isolated from the human hepatocyte cell line HuH7

Yasuyuki Fujimoto, Hiroyuki Itabe, Jun Sakai et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2003 · 329 citations

Life Sciences, Biochemistry, Cell Biology +12

Axonal Guillain-Barr� syndrome: Relation to anti-ganglioside antibodies andCampylobacter jejuni infection in Japan

Kazue Ogawara, Satoshi Kuwabara, Masahiro Mori et al. · Annals of Neurology · 2000 · 326 citations

Life Sciences, Neurology, Neuroscience +17